Synergistic inhibition of endochondral bone formation by silencing Hif1α and Runx2 in trauma-induced heterotopic ossification

Molecular Therapy

Volumn 19, Issue 8, 2011, Pages 1426-1432

  Lin, Lin ^a   Shen, Qi ^b   Leng, Huijie ^a   Duan, Xiaoning ^a   Fu, Xin ^a   Yu, Changlong ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ACHILLES TENDON; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENCHONDRAL OSSIFICATION; FETUS; GENE EXPRESSION REGULATION; GENE SILENCING; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN DEFECT; PROTEIN DEPLETION; PROTEIN FUNCTION; RAT; TENOTOMY; TRANSCRIPTION REGULATION;

ANIMALIA; LENTIVIRUS;

EID: 79961021928     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.101     Document Type: Article

References (33)

1. Pape, HC, Marsh, S, Morley, JR, Krettek, C and Giannoudis, PV (2004). Current concepts in the development of heterotopic ossification. J Bone Joint Surg Br 86: 783-787. (Pubitemid 39173460)
2. Wang, Y, Wan, C, Deng, L, Liu, X, Cao, X, Gilbert, SR et al. (2007). The hypoxiainducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117: 1616-1626. (Pubitemid 46871346)
3. Araldi, E and Schipani, E (2010). Hypoxia, HIFs and bone development. Bone 47: 190-196.
4. Amarilio, R, Viukov, SV, Sharir, A, Eshkar-Oren, I, Johnson, RS and Zelzer, E (2007). HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134: 3917-3928. (Pubitemid 350187350)
5. Dilling, CF, Wada, AM, Lazard, ZW, Salisbury, EA, Gannon, FH, Vadakkan, TJ et al. (2010). Vessel formation is induced prior to the appearance of cartilage in BMP-2- mediated heterotopic ossification. J Bone Miner Res 25: 1147-1156.
6. Tseng, WP, Yang, SN, Lai, CH and Tang, CH (2010). Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts. J Cell Physiol 223: 810-818.
7. Alliston, T, Choy, L, Ducy, P, Karsenty, G and Derynck, R (2001). TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20: 2254-2272. (Pubitemid 32410595)
8. Komori, T, Yagi, H, Nomura, S, Yamaguchi, A, Sasaki, K, Deguchi, K et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764. (Pubitemid 27516178)
9. Otto, F, Thornell, AP, Crompton, T, Denzel, A, Gilmour, KC, Rosewell, IR et al. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771. (Pubitemid 27516179)
10. Ducy, P, Zhang, R, Geoffroy, V, Ridall, AL and Karsenty, G (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754. (Pubitemid 27516177)
11. Lin, L, Chen, L, Wang, H, Wei, X, Fu, X, Zhang, J et al. (2006). Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model. Biochem Biophys Res Commun 349: 564-572. (Pubitemid 44349141)
12. Xue, T, Mao, Z, Lin, L, Hou, Y, Wei, X, Fu, X et al. (2010). Non-virus-mediated transfer of siRNAs against Runx2 and Smad4 inhibit heterotopic ossification in rats. Gene Ther 17: 370-379.
13. Lin, L, Shen, Q, Xue, T and Yu, C (2010). Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: expression of bone and cartilage related genes. Bone 46: 425-431.
14. Muller, WA, Ratti, CM, McDonnell, SL and Cohn, ZA (1989). A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170: 399-414. (Pubitemid 19204271)
15. Wan, C, Shao, J, Gilbert, SR, Riddle, RC, Long, F, Johnson, RS et al. (2010). Role of HIF- 1alpha in skeletal development. Ann N Y Acad Sci 1192: 322-326.
16. Peng, H, Usas, A, Olshanski, A, Ho, AM, Gearhart, B, Cooper, GM et al. (2005). VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20: 2017-2027. (Pubitemid 41532787)
17. Peng, H, Wright, V, Usas, A, Gearhart, B, Shen, HC, Cummins, J et al. (2002). Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751-759.
18. Shomento, SH, Wan, C, Cao, X, Faugere, MC, Bouxsein, ML, Clemens, TL et al. (2010). Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development. J Cell Biochem 109: 196-204.
19. Kanichai, M, Ferguson, D, Prendergast, PJ and Campbell, VA (2008). Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxiainducible factor (HIF)-1alpha. J Cell Physiol 216: 708-715.
20. Kobayashi, H, Gao, Y, Ueta, C, Yamaguchi, A and Komori, T (2000). Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem Biophys Res Commun 273: 630-636. (Pubitemid 30599036)
21. Enomoto, H, Furuichi, T, Zanma, A, Yamana, K, Yoshida, C, Sumitani, S et al. (2004). Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J Cell Sci 117(Pt 3): 417-425. (Pubitemid 38181203)
22. Mori, S, Yoshikawa, H, Hashimoto, J, Ueda, T, Funai, H, Kato, M et al. (1998). Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. Bone 22: 99-105. (Pubitemid 28058499)
23. Yu, PB, Deng, DY, Lai, CS, Hong, CC, Cuny, GD, Bouxsein, ML et al. (2008). BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14: 1363-1369.
24. Otsuru, S, Tamai, K, Yamazaki, T, Yoshikawa, H and Kaneda, Y (2007). Bone marrowderived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 354: 453-458. (Pubitemid 46161345)
25. Rüster, B, Göttig, S, Ludwig, RJ, Bistrian, R, Müller, S, Seifried, E et al. (2006). Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108: 3938-3944. (Pubitemid 44864580)
26. Reddi, AH (1994). Bone and cartilage differentiation. Curr Opin Genet Dev 4: 737-744. (Pubitemid 24322911)
27. Suda, RK, Billings, PC, Egan, KP, Kim, JH, McCarrick-Walmsley, R, Glaser, DL et al. (2009). Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 27: 2209-2219.
28. Kaplan, FS, Glaser, DL, Shore, EM, Pignolo, RJ, Xu, M, Zhang, Y et al. (2007). Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89: 347-357. (Pubitemid 46214354)
29. Chang, LJ and Gay, EE (2001). The molecular genetics of lentiviral vectors-current and future perspectives. Curr Gene Ther 1: 237-251.
30. Tanaka, T, Kojima, I, Ohse, T, Inagi, R, Miyata, T, Ingelfinger, JR et al. (2005). Hypoxiainducible factor modulates tubular cell survival in cisplatin nephrotoxicity. Am J Physiol Renal Physiol 289: F1123-F1133. (Pubitemid 41447069)
31. Rubinson, DA, Dillon, CP, Kwiatkowski, AV, Sievers, C, Yang, L, Kopinja, J et al. (2003). A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406. (Pubitemid 36278858)
32. Hu, W, Huang, J, Mahavadi, S, Li, F and Murthy, KS (2006). Lentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscle. Biochem Biophys Res Commun 343: 1038-1044. (Pubitemid 44313844)
33. Hou, Y, Mao, Z, Wei, X, Lin, L, Chen, L, Wang, H et al. (2009). Effects of transforming growth factor-beta1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing. Matrix Biol 28: 324-335.